Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · Real-Time Price · USD
2.430
+0.165 (7.28%)
Nov 4, 2024, 4:00 PM EST - Market closed

Syros Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
6520373202609293
Upgrade
Market Cap Growth
-29.54%179.01%-64.04%-66.84%107.64%56.45%
Upgrade
Enterprise Value
67153-108101563206
Upgrade
Last Close Price
2.437.793.5932.60108.5069.10
Upgrade
PE Ratio
--1.34-0.48-2.36-5.95-3.68
Upgrade
PS Ratio
231.5820.394.888.6040.35147.97
Upgrade
PB Ratio
-5.1812.160.572.376.723.70
Upgrade
P/FCF Ratio
-0.58-1.84-0.58-2.00-10.03-4.02
Upgrade
P/OCF Ratio
-0.58-1.85-0.59-2.03-10.62-4.87
Upgrade
EV/Sales Ratio
173.8315.38-7.254.2937.27104.14
Upgrade
EV/EBITDA Ratio
-0.36-1.230.87-1.04-7.10-2.75
Upgrade
EV/EBIT Ratio
-0.35-1.210.85-1.01-6.84-2.66
Upgrade
EV/FCF Ratio
-0.39-1.390.87-1.00-9.27-2.83
Upgrade
Debt / Equity Ratio
-5.413.730.500.760.730.33
Upgrade
Debt / FCF Ratio
-0.60-0.56-0.51-0.65-1.09-0.36
Upgrade
Asset Turnover
0.000.050.070.120.080.02
Upgrade
Quick Ratio
2.053.806.634.236.164.74
Upgrade
Current Ratio
2.253.956.874.336.244.87
Upgrade
Return on Equity (ROE)
-776.96%-227.94%-88.90%-98.49%-99.02%-95.63%
Upgrade
Return on Assets (ROA)
-59.88%-38.32%-36.95%-31.37%-28.32%-37.85%
Upgrade
Return on Capital (ROIC)
-94.28%-58.55%-46.22%-40.46%-39.28%-52.89%
Upgrade
Earnings Yield
-150.14%-81.23%-130.36%-42.86%-13.80%-25.72%
Upgrade
FCF Yield
-153.58%-54.29%-171.19%-49.91%-9.97%-24.85%
Upgrade
Buyback Yield / Dilution
-31.77%-124.24%-102.00%-35.79%-14.49%-23.17%
Upgrade
Total Shareholder Return
-31.77%-124.24%-102.00%-35.79%-14.49%-23.17%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.